Nathan P Wiederhold Selected Research

Azoles

1/2022	Species Distribution and Antifungal Susceptibilities of Aspergillus Section Fumigati Isolates in Clinical Samples from the United States.
1/2021	Ibrexafungerp Demonstrates In Vitro Activity against Fluconazole-Resistant Candida auris and In Vivo Efficacy with Delayed Initiation of Therapy in an Experimental Model of Invasive Candidiasis.
1/2020	Aspergillus fumigatus and pan-azole resistance: who should be concerned?
10/2019	Extended-Interval Dosing of Rezafungin against Azole-Resistant Aspergillus fumigatus.
1/2019	In Vitro Activities of the Novel Investigational Tetrazoles VT-1161 and VT-1598 Compared to the Triazole Antifungals against Azole-Resistant Strains and Clinical Isolates of Candida albicans.
11/2018	Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species.
1/2017	Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis.
1/2017	Antifungal resistance: current trends and future strategies to combat.
1/2017	Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification.
10/2015	Emergence of Azole Resistance in Aspergillus.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nathan P Wiederhold Research Topics

Disease

35	Infections 06/2021 - 01/2005
17	Invasive Fungal Infections 02/2021 - 12/2007
16	Aspergillosis 01/2022 - 12/2003
13	Body Weight (Weight, Body) 01/2020 - 02/2006
13	Invasive Pulmonary Aspergillosis 05/2015 - 10/2004
12	Invasive Candidiasis 08/2022 - 01/2008
11	Mycoses (Diseases, Fungus) 12/2021 - 08/2003
8	Mucormycosis 04/2021 - 07/2013
4	Fusariosis 07/2021 - 01/2006
3	Candidiasis (Moniliasis) 08/2022 - 01/2012
3	Cryptococcal Meningitis 11/2018 - 01/2016
3	Coccidioidomycosis 01/2018 - 12/2015
3	Cryptococcosis 12/2016 - 02/2013
2	Fever (Fevers) 06/2021 - 04/2017
2	Cystic Fibrosis (Mucoviscidosis) 06/2021 - 03/2017
2	Candidemia 07/2019 - 09/2013
2	Chronic Granulomatous Disease 06/2019 - 01/2017
2	Drug-Related Side Effects and Adverse Reactions 03/2018 - 01/2018
2	Meningoencephalitis 02/2013 - 06/2012
2	Pulmonary Edema 03/2010 - 09/2009
2	Neoplasms (Cancer) 12/2005 - 01/2005
1	Breakthrough Infections 06/2021
1	Coinfection 06/2021
1	Surgical Wound 06/2021
1	Legg-Calve-Perthes Disease (Perthes Disease) 06/2021
1	Wounds and Injuries (Trauma) 06/2021
1	Pain (Aches) 06/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Leukemia 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021
1	scedosporiosis 01/2020
1	Bacterial Infections (Bacterial Infection) 12/2019
1	Granuloma 06/2019
1	Weight Loss (Weight Reduction) 03/2019
1	Diarrhea 03/2019
1	Colitis 03/2019
1	Ileitis 03/2019
1	Pythiosis 03/2019
1	Alopecia (Baldness) 01/2019

Drug/Important Bio-Agent (IBA)

18	EchinocandinsIBA 10/2019 - 12/2007
14	AzolesIBA 01/2022 - 06/2007
11	posaconazole FDA Link 06/2021 - 03/2010
11	Fluconazole (Zonal)FDA LinkGeneric 01/2021 - 02/2013
10	Caspofungin (Cancidas)FDA Link 11/2019 - 08/2003
9	Voriconazole (Vfend)FDA LinkGeneric 01/2019 - 06/2009
7	Antifungal AgentsIBA 01/2018 - 03/2008
7	Pharmaceutical PreparationsIBA 01/2017 - 04/2005
7	Amphotericin B (Amphotericin)FDA LinkGeneric 10/2015 - 02/2006
6	isavuconazoleIBA 06/2021 - 01/2016
5	Itraconazole (Sporanox)FDA LinkGeneric 01/2019 - 04/2006
5	Micafungin (FK463)FDA Link 01/2017 - 08/2003
4	olorofimIBA 07/2021 - 11/2016
4	VT-1161IBA 01/2019 - 12/2015
3	ibrexafungerpIBA 08/2022 - 01/2018
3	Investigational DrugsIBA 08/2022 - 12/2015
3	liposomal amphotericin B FDA Link 04/2021 - 07/2013
3	EnzymesIBA 01/2020 - 01/2017
3	VT-1598IBA 01/2019 - 01/2018
3	galactomannanIBA 04/2016 - 12/2009
3	polyglucosanIBA 04/2016 - 03/2008
2	CytokinesIBA 04/2021 - 06/2007
2	Pentamidine (NebuPent)FDA LinkGeneric 02/2021 - 01/2006
2	T-2307IBA 02/2021 - 02/2015
2	ProdrugsIBA 01/2020 - 01/2020
2	1-aminobenzotriazoleIBA 01/2020 - 01/2020
2	TriazolesIBA 01/2020 - 01/2019
2	APX001AIBA 01/2020 - 01/2015
2	RezafunginIBA 10/2019 - 11/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2019 - 06/2015
2	Ergosterol (Lumisterol)IBA 01/2019 - 03/2018
2	VT-1129IBA 11/2018 - 01/2018
2	glucan synthaseIBA 01/2018 - 08/2003
2	Indicators and Reagents (Reagents)IBA 04/2016 - 01/2005
2	Biomarkers (Surrogate Marker)IBA 08/2013 - 03/2008
2	Anidulafungin FDA Link 05/2007 - 08/2003
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2006 - 12/2003
2	GliotoxinIBA 12/2005 - 01/2005
1	ChemokinesIBA 04/2021
1	venetoclaxIBA 01/2021
1	DNA ProbesIBA 11/2020
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2020
1	mannoproteinsIBA 01/2020
1	Volatile Oils (Essential Oils)IBA 12/2019
1	NADPH Oxidases (NAD(P)H oxidase)IBA 06/2019
1	Formaldehyde (Formol)FDA Link 03/2019
1	Coloring Agents (Dyes)IBA 03/2019
1	ImmunosorbentsIBA 03/2019
1	Methenamine (Hexamine)IBA 03/2019
1	ParaffinIBA 03/2019
1	ebericolIBA 01/2019
1	HMGB1 Protein (HMG1)IBA 01/2019
1	SterolsIBA 01/2019
1	ebselenIBA 10/2018

Therapy/Procedure

29	Therapeutics 01/2022 - 12/2003
3	Salvage Therapy 01/2019 - 03/2010
2	Lung Transplantation 06/2021 - 03/2017
1	Hip Replacement Arthroplasty (Total Hip Replacement) 06/2021
1	Remission Induction 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Intraperitoneal Injections 11/2019